Ann: Appendix 4C - quarterly, page-42

Something just doesn't feel right in RHY at the moment.
Delays, Lack of communication, Change of Chairman.. Smells like there is some internal mis-alignment.

I was also surprised that Glenn's incentive was around share price appreciation as I saw very little progress here and little to no promotion. And if they are now trying to focus him on commercialization this coming year, what did he actually focus on in 2019?

And I have to say that the "scientist" from CSIRO. The fact that they got through 5 studies and then had to change their biomarkers.. I have many questions about that whole fiasco..

I am still a holder but becoming increasingly nervous as the lack of communication continues and we are all left in limbo. The fact that also the price has deteriorated to this level also points that the smart money is also concerned because it is not buying and someone is selling.